Drug interactions
Talimogene laherparepvec + Valganciclovir
Severity: Major
Talimogene laherparepvec and Valganciclovir: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Talimogene laherparepvec is a live, attenuated herpes simplex virus that depends on replication. Valganciclovir is converted to ganciclovir, which is active against herpes viruses and may reduce the efficacy of the oncolytic virus.
What this interaction means in plain words
Talimogene laherparepvec and Valganciclovir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Talimogene laherparepvec belongs to Oncology; Valganciclovir belongs to Anti Virals.
Why it happens
Antiviral inhibition of viral DNA replication, which may blunt the live oncolytic virus.
What to do
Avoid antiherpetic antivirals during talimogene therapy where possible. If treatment of a herpetic infection is required, treat it and reassess the oncolytic regimen.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Talimogene laherparepvec and Valganciclovir, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Valganciclovir
Other interactions of Talimogene laherparepvec
Frequently asked questions
Can I take Talimogene laherparepvec with Valganciclovir?
MediHelp rates the interaction as major. Talimogene laherparepvec and Valganciclovir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Talimogene laherparepvec is a live, attenuated herpes simplex virus that depends on replication. Valganciclovir is converted to ganciclovir, which is active against herpes viruses and may reduce the efficacy of the oncolytic virus.
How serious is the interaction between Talimogene laherparepvec and Valganciclovir?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid antiherpetic antivirals during talimogene therapy where possible. If treatment of a herpetic infection is required, treat it and reassess the oncolytic regimen.
What other medicines interact with Valganciclovir?
MediHelp also lists interactions of Valganciclovir with, for example, Didanosine, Ganciclovir, Liposomal doxorubicin. The full list is on the Valganciclovir page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
